TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC
Clinical trial NCT03905967 · UNKNOWN
Trial details
- NCT number
- NCT03905967
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-16
- Primary completion
- 2023-04-15
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.